Khan, K. . (2025). Pioglitazone for Primary and Secondary Prevention of Cardiovascular and Renal Outcomes in Patients with or at High Risk of Type 2 Diabetes: A Meta-Analysis. International Journal of Medical and Biomedical Studies, 9(1), 259–264. https://doi.org/10.32553/ijmbs.v9i1.3091